Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/1995
10/03/1995CA1337195C 4,5,7,8-tetrahydro-6h-thiazolo[5,4-d]azepines, their preparation and their use as pharmaceuticals
10/03/1995CA1337193C Muscarinic receptor antagonists
10/03/1995CA1337182C Compounds related to antibiotic tan-749 and their production
10/03/1995CA1337176C Pharmaceutical compositions for the inhibition of tumor metastasis
10/03/1995CA1337175C Use of zofenopril for the treatment of rheumatoid arthritis
10/02/1995CA2146085A1 Steroids containing an aminosubstituted chain in position 20; process and intermediates therefor; their use as drugs and pharmaceutical compositions containing them
10/02/1995CA2145346A1 Cosmetic or dermatological compositions and process for preparing them
10/01/1995CA2146059A1 Imidazole-containing inhibitors of farnesyl protein transferase
10/01/1995CA2145614A1 Intermediates and processes for preparing benzothiophene compounds
10/01/1995CA2144499A1 Mono- and bicyclic dna gyrase inhibitors
09/1995
09/30/1995CA2145229A1 Suppressory compositions against hepatic metastases of tumors
09/30/1995CA2144669A1 Biphenyl derivatives
09/29/1995CA2145584A1 Styrene-isoprene-styrene copolymer-based transdermal matrix system for the administration of an oestrogen and/or a progestogen
09/29/1995CA2145579A1 Eva-based transdermal matrix system for the administration of an oestrogen and/or a progestogen
09/29/1995CA2145443A1 Purine derivatives and suppressants for inflammatory diseases
09/28/1995WO1995025814A1 Oligonucleotide n3'→p5' phosphoramidates: synthesis and compounds; hybridization and nuclease resistance properties
09/28/1995WO1995025809A1 Compacted nucleic acids and their delivery to cells
09/28/1995WO1995025807A1 Inhibition of arterial smooth muscle cell proliferation
09/28/1995WO1995025806A2 Packaging-deficient lentiviruses
09/28/1995WO1995025805A1 Recombinant viruses coding for a glutamate decarboxylase (gad) activity
09/28/1995WO1995025804A1 Recombinant adenoviruses coding for brain-derived neurotrophic factor (bdnf)
09/28/1995WO1995025803A1 RECOMBINANT ADENOVIRUSES CODING FOR ACIDIC FIBROBLAST GROWTH FACTOR (aFGF)
09/28/1995WO1995025802A1 RECOMBINANT ADENOVIRUSES FOR GLIAL MATURATION FACTOR BETA (GMF-β)
09/28/1995WO1995025800A1 Gene-therapeutic process using antibiotic-resistance gene-free dna vectors
09/28/1995WO1995025788A1 Novel mutated viruses, anti-viral compounds and novel methods of making vaccines
09/28/1995WO1995025751A1 Novel heparin-like sulfated polysaccharides
09/28/1995WO1995025736A1 Glucosidic derivatives of n-acyl alkylamines exerting neuroprotective, neurotrophic and anti-inflammatory action, useful in acute and chronic disorders of the central nervous system connected with excitotoxicity
09/28/1995WO1995025733A1 4-p-fluorobenzoyl-1-piperidinyl-propoxy-chromen-4-one derivatives, their preparation and their use in the treatment of psychosis and schizophrenia
09/28/1995WO1995025732A1 N-p-HALOBENZOYLMETHYL DERIVATIVES OF 4-(p-FLUOROPHENYL)-3-((3,4-METHYLENE-DIOXY)PHENOXY)METHYL)PIPERIDINE
09/28/1995WO1995025730A1 Nicotinic acid derivative and herbicide
09/28/1995WO1995025727A1 Naphthylamides as central nervous system agents
09/28/1995WO1995025726A1 QUINAZOLINYL-AMINO DERIVATIVES HAVING α-ANTAGONIST ACTIVITY
09/28/1995WO1995025723A1 Anilide derivatives as fungicides
09/28/1995WO1995025721A1 New 1,4-disubstituted piperidine derivatives useful as medicaments acting on the glutamate receptor
09/28/1995WO1995025718A1 Vitamin-d amide derivatives
09/28/1995WO1995025548A2 Hypocholesterolemic, antiatherosclerotic and hypotriglyceridemic mercaptoacetylamide derivatives
09/28/1995WO1995025545A1 The use of dimeticone as a transport and carrier system and/or drug delivery system
09/28/1995WO1995025544A1 Gel for treatment of skin diseases and for disinfection of the skin
09/28/1995WO1995025542A1 Composition including a recombinant plasmid, and uses thereof as a vaccine and drug
09/28/1995WO1995025533A1 PROTEASOME REGULATION OF NF-λB ACTIVITY
09/28/1995WO1995025525A1 The use of dimeticone for the local antibacterial therapy and/or the prevention and therapy of helicobacter pylori (hp) associated syndromes and infectious diseases
09/28/1995WO1995025524A1 USE OF GINSENOSIDE Ro OR A PLANT EXTRACT CONTAINING SAME TO PROMOTE COLLAGEN SYNTHESIS
09/28/1995WO1995025523A1 Novel pharmaceutical composition for skin diseases
09/28/1995WO1995025522A1 Use of phosphorus derivatives of alkaloids for treating endocrinopathies
09/28/1995WO1995025521A1 Solid dose forms containing bismuth
09/28/1995WO1995025520A1 Thioprostaglandins and -prostaglandin-like compounds and therapeutic uses thereof
09/28/1995WO1995025519A1 Hypocholesterolemic, antiatherosclerotic and hypotriglyceridemic mercaptoacetylamide disulfide derivatives
09/28/1995WO1995025518A1 Aqueous solution of levocabastine for ophthalmic use
09/28/1995WO1995025517A1 Remedy for infectious diseases
09/28/1995WO1995025516A1 Pharmaceutical formulations containing beta-lactam antibiotics and an alkyl sulphate surfactant
09/28/1995WO1995025515A1 Inhibition of growth of cancer cells
09/28/1995WO1995025514A1 Compounds useful as anxiolytic, sedative, and hypnotic agents
09/28/1995WO1995025513A1 Zinc compound and cyclodextrine for treatment of gastric disorders
09/28/1995WO1995025512A1 Process for making solid dose forms containing bismuth
09/28/1995WO1995025511A1 Low dosage ketoprofen
09/28/1995WO1995025510A1 Pharmaceutical compositions containing alkylthioalkanoic acids or derivatives thereof and their use in the treatment of mycobacterial infections and as antiseptic
09/28/1995WO1995025509A2 Use of n-acyl derivatives of aminoalcohols in the manufacture of a medicament for practising neuroprotective action in neuropathological states connected with excitotoxicity
09/28/1995WO1995025508A1 Treating cyclosporine-induced nephrotoxicity
09/28/1995WO1995025507A1 Retinal-containing composition
09/28/1995WO1995025502A1 Polyglycerine polyricinoleates
09/28/1995WO1995025443A1 Tocolytic oxytocin receptor antagonists
09/28/1995WO1995025429A1 Mts gene, mutations therein, and methods for diagnosing cancer using mts gene sequence
09/28/1995WO1995023855A3 Genes and genetic elements associated with control of neoplastic transformation in mammalian cells
09/28/1995WO1995023806A3 Ureido derivatives of naphthalenephosphonic acids and process for their preparation
09/28/1995DE4430803C1 Cough mixture
09/28/1995DE4410822A1 Neue Piperidin-Derivate New piperidine derivatives
09/28/1995DE4410601A1 Neue 2.4-Diphosphonoglutarsäurederivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel New 2.4-Diphosphonoglutarsäurederivate, process for their preparation and pharmaceutical compositions containing them
09/28/1995DE4410238A1 Hautpflegemittel Skin Care Products
09/28/1995DE4409949A1 New calcium alkali metal citrate salts
09/28/1995DE4409948A1 New calcium alkali metal citrate salts
09/28/1995DE4409804A1 Use of deoxyspergualin to prepare medicament
09/28/1995CA2186242A1 Gene-therapeutic process using antibiotic-resistance gene-free dna vectors
09/28/1995CA2186129A1 Tocolytic oxytocin receptor antagonists
09/28/1995CA2186045A1 Gel for treatment of skin diseases and for disinfection of the skin
09/28/1995CA2186010A1 New 1,4-disubstituted piperidine derivatives useful as medicaments acting on the glutamate receptor
09/28/1995CA2185882A1 The use of dimeticone for the local antibacterial therapy and/or the prevention and therapy of helicobacter pylori (hp) associated syndromes and infectious diseases
09/28/1995CA2185825A1 Agent for the treatment of infections
09/28/1995CA2185813A1 Vitamin-d amide derivatives
09/28/1995CA2185805A1 Low dosage ketoprofen
09/28/1995CA2184409A1 Recombinant adenoviruses coding for acidic fibroblast growth factor (afgf)
09/28/1995CA2184408A1 Recombinant adenoviruses for glial maturation factor beta (gmf-.beta.)
09/28/1995CA2184200A1 Recombinant viruses, preparation and use in genic therapy
09/28/1995CA2163251A1 4-p-fluorobenzoyl-1-piperidinyl-propoxy-chromen-4-one derivatives
09/28/1995CA2162147A1 Mts gene, mutations therein, and methods for diagnosing cancer using mts gene sequence
09/27/1995EP0674008A1 Preparation of optically active cyclohexenol and cyclohexenyl acetic acid via an enzymatic process followed by a rearrangement reaction and their use as intermediates in the synthesis of indolobenzoquinoline derivatives
09/27/1995EP0674007A1 Process for the preparation of pilocarpine
09/27/1995EP0674004A1 MSRV1 virus and pathogenic and/or infections agent MSRV2 linked to multiple sclerosis, their nucleic components and their applications
09/27/1995EP0673938A2 Novel purine derivatives and pharmaceutically acceptable salts thereof
09/27/1995EP0673937A1 Bicyclic heterocyclic sulfonamide and sulfonic ester derivatives
09/27/1995EP0673934A1 Aminoalkyl benzothiazolinones, process for their preparation and pharmaceutical compositions containing them
09/27/1995EP0673933A1 Aminoalkyl benzoxazolinones and benzothiazolinones process for their preparation and compositions containing them
09/27/1995EP0673932A1 Sulfonamidocarbonyl-pyridine-2-carboxamides as well as their pyridine-N-oxides, process for their preparation and their use as medicaments
09/27/1995EP0673931A1 Sulfonamidocarbonyl-pyridine-2-carboxamides and their pyridine-N-oxides, process for their preparation and their use as medicaments
09/27/1995EP0673930A1 Substituted heterocyclic carboxylic acid amide esters, their preparation and their use as medicaments
09/27/1995EP0673929A1 Substituted heterocyclic carboxylic acid amides, their preparation and their use as medicaments
09/27/1995EP0673928A1 Novel N-(3,4-dichlorophenyl-propyl)-piperidine derivatives as selective human NK3-receptor antagonists
09/27/1995EP0673927A1 4-[2-indanyl-1-one]alkylpiperidines as anticholinergic agents
09/27/1995EP0673913A1 Calcium-alkali-citrate compounds and their use as medicaments
09/27/1995EP0673650A1 Pharmaceutical sustained-release dosage forms containing alfusozine hydrochloride
09/27/1995EP0673649A1 Pharmaceutical compositions for the prolonged release of trimetazidine after oral administration
1 ... 6980 6981 6982 6983 6984 6985 6986 6987 6988 6989 6990 6991 6992 6993 6994 6995 6996 6997 6998 6999 7000 ... 7860